Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19). Since its emergence, the COVID-19 pandemic has not only distressed medical services but also caused economic upheavals, marking urgent the need for effective therapeutics. The experie...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Enzyme Inhib Med Chem
Päätekijät: Chiou, Wei-Chung, Hsu, Meng-Shiuan, Chen, Yun-Ti, Yang, Jinn-Moon, Tsay, Yeou-Guang, Huang, Hsiu-Chen, Huang, Cheng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2021
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7808739/
https://ncbi.nlm.nih.gov/pubmed/33430659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2020.1850710
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia